Patton Fund Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-921
Closed -$207K 394
2026
Q1
$207K Hold
921
0.04% 471
2025
Q4
$222K Sell
921
-46
-5% -$11.8K 0.03% 341
2025
Q3
$265K Sell
967
-8,547
-90% -$2.33M 0.05% 208
2025
Q2
$2.45M Sell
9,514
-6,859
-42% -$1.64M 0.54% 60
2025
Q1
$3.67M Sell
16,373
-4,743
-22% -$1.11M 0.89% 50
2024
Q4
$4.83M Sell
21,116
-3,653
-15% -$880K 0.95% 45
2024
Q3
$6.05M Buy
+24,769
New +$5.53M 1.25% 24
2020
Q1
Sell
-1,879
Closed -$291K 95
2019
Q4
$291K Buy
+1,879
New +$271K 0.1% 76

Other funds holding RMD

Patton Fund Management's RMD Position: Q2 2026 in Review

Patton Fund Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 921 shares — an estimated $207K sold.

Patton Fund Management first reported a position in RMD in Q4 2019 and held it in 8 quarters. The position peaked at $6.05M in Q3 2024. 251 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Patton Fund Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 921 ResMed shares in Q2 2026, an estimated $207K.
  • Patton Fund Management first reported a position in ResMed in Q4 2019 and held it in 8 quarters.
  • Patton Fund Management's ResMed position peaked at $6.05M in Q3 2024.
  • 251 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.